Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback